Lidings supports the first ever The Legal 500 GC Summit in Russia — a legal summit organized by the leading international legal rating agency The Legal 500 for corporate lawyers of the large Russian and international companies operating in the country.
A new ranking for the world’s best law firms and individual lawyers annually provided by The Legal 500 EMEA once again confirms Lidings position as one of the strongest legal advisors in corporate and M&A and dispute resolution in Russia.
Lidings supports the first ever Global Arbitration Review’s event in Russia, the GAR Live Moscow 2019 conference, taking place on March 21st at Moscow’s InterContinental hotel.
Lidings once again takes top positions as the leading legal advisor in the areas of Dispute Resolution, Corporate and M&A, and Life Sciences in Russia as a result of the best law firms’ research annually conducted by Chambers and Partners Europe.
The World Trademark Review, professional publication annually identifying the most prominent lawyers around the world focused on trademark legal issues, once again lists Lidings’ Managing Partner Andrey Zelenin among the best lawyers in Russia.
Lidings has become an official authorized provider of legal services for Participants and Residents of the Skolkovo Technopark.
Lidings Managing Partner Andrey Zelenin and Partner Stepan Guzey will take part in the Russian Law Week 2018 in London on November 12-14.
Collection of articles in English written by leading Russian experts in the field of dispute resolution. The book is published in Russia under the umbrella of Research and Educational Centre “Law and Business MSU”, Lomonosov Moscow State University Faculty of Law.
Lidings experts authored the following sections: Summary Jurisdiction, Proceedings in Commercial Courts with the Participation of a Foreign Person, Resolving Intellectual Property Disputes and Resolving Labour Disputes.
Lidings experts have authored the The Pharma Legal Handbook: Russia — practical directory focused on the key aspects of legislative regulation of pharmaceutical industry in Russia.
The site uses cookie technology to ensure optimal performance, analyze usage and improve user experience. By continuing to use the site, you consent to the placement of cookies on your device on the terms set out in the Privacy Policy.
To ensure optimal performance, analyze usage and improve user experience, the website may use web analytics systems (including Yandex.Metrica), which may place cookies on your device.
By continuing to use the website, you agree to the use of these technologies and the placement of cookies. You can delete cookies from your device through your browser settings and you can block the placement of cookies, however, in doing so, some website features may not be available due to the engine's technological limitations.
You can find more information in the Privacy Policy.